These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30584005)

  • 21. Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update.
    Mancini GB; Tashakkor AY; Baker S; Bergeron J; Fitchett D; Frohlich J; Genest J; Gupta M; Hegele RA; Ng DS; Pearson GJ; Pope J
    Can J Cardiol; 2013 Dec; 29(12):1553-68. PubMed ID: 24267801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Statin intolerance].
    Tonstad S
    Tidsskr Nor Laegeforen; 2017 Jan; 137(1):36-38. PubMed ID: 28073228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin intolerance: now a solved problem.
    Sikka P; Kapoor S; Bindra VK; Sharma M; Vishwakarma P; Saxena KK
    J Postgrad Med; 2011; 57(4):321-8. PubMed ID: 22120862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin intolerance.
    Ahmad Z
    Am J Cardiol; 2014 May; 113(10):1765-71. PubMed ID: 24792743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent Safety and Efficacy of Evolocumab in Patients with Statin Intolerance: a Subset Analysis of the OSLER Open-Label Extension Studies.
    Cho L; Dent R; Stroes ESG; Stein EA; Sullivan D; Ruzza A; Flower A; Somaratne R; Rosenson RS
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):365-372. PubMed ID: 30073585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New insights into managing symptoms during statin therapy.
    Robinson JG
    Prog Cardiovasc Dis; 2019; 62(5):390-394. PubMed ID: 31669768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in the management of statin myopathy.
    Gallo A; Perregaux J; Bruckert E
    Curr Opin Endocrinol Diabetes Obes; 2021 Apr; 28(2):142-151. PubMed ID: 33278129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overcoming toxicity and side-effects of lipid-lowering therapies.
    Wilkinson MJ; Laffin LJ; Davidson MH
    Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):439-52. PubMed ID: 24840269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statin intolerance.
    Laufs U; Scharnagl H; März W
    Curr Opin Lipidol; 2015 Dec; 26(6):492-501. PubMed ID: 26780003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin therapy in athletes and patients performing regular intense exercise - Position paper from the International Lipid Expert Panel (ILEP).
    Katsiki N; Mikhailidis DP; Bajraktari G; Miserez AR; Cicero AFG; Bruckert E; Serban MC; Mirrakhimov E; Alnouri F; Reiner Ž; Paragh G; Sahebkar A; Banach M;
    Pharmacol Res; 2020 May; 155():104719. PubMed ID: 32087236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuromuscular complications of statins.
    Ahn SC
    Phys Med Rehabil Clin N Am; 2008 Feb; 19(1):47-59, vi. PubMed ID: 18194749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statin-induced myopathy: a review and update.
    Abd TT; Jacobson TA
    Expert Opin Drug Saf; 2011 May; 10(3):373-87. PubMed ID: 21342078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Narrative review: statin-related myopathy.
    Joy TR; Hegele RA
    Ann Intern Med; 2009 Jun; 150(12):858-68. PubMed ID: 19528564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statin adverse effects: patients' experiences and laboratory monitoring of muscle and liver injuries.
    Chaipichit N; Krska J; Pratipanawatr T; Jarernsiripornkul N
    Int J Clin Pharm; 2015 Apr; 37(2):355-64. PubMed ID: 25630895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Statin myopathy--rarity or reality?].
    Pella D
    Vnitr Lek; 2010 Sep; 56(9 Suppl):972-6. PubMed ID: 21137170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient.
    Cheeley MK; Saseen JJ; Agarwala A; Ravilla S; Ciffone N; Jacobson TA; Dixon DL; Maki KC
    J Clin Lipidol; 2022; 16(4):361-375. PubMed ID: 35718660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STATIN-ASSOCIATED INTOLERANCE AND ITS PREVENTION.
    Karsanidze A; Antelava N; Gorgasledze N; Ghonghadze M; Okudzhava M; Pachkoria K
    Georgian Med News; 2018 Jun; (279):155-161. PubMed ID: 30035739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addressing statin adverse effects in the clinic: the 5 Ms.
    Katz DH; Intwala SS; Stone NJ
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):533-42. PubMed ID: 24770611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statin-induced myopathy in a patient with previous poliomyelitis.
    Martikainen MH; Gardberg M; Kohonen Ia; Lähdesmäki J
    Am J Phys Med Rehabil; 2013 Nov; 92(11):1031-4. PubMed ID: 23370588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MY APPROACH to Managing Statin-Associated Muscle Symptoms.
    Thompson PD
    Trends Cardiovasc Med; 2017 Feb; 27(2):160-161. PubMed ID: 28107840
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.